HOME >> BIOLOGY >> NEWS
New anthrax inhibitor could combat antibiotic-resistant strains

Note: This press release was updated on August 23, 2006.

Troy, N.Y. - In a new approach to treating anthrax exposure, a team of scientists has created an inhibitor designed to tackle the growing threat of antibiotic-resistant strains. Reporting in this week's online early edition of the Proceedings of the National Academy of Sciences (PNAS), researchers from Rensselaer Polytechnic Institute and the University of Toronto describe the new anthrax toxin inhibitor, which performed successfully in both laboratory and animal tests.

Anthrax toxin, secreted by the anthrax bacterium, is made of proteins and toxic enzymes that bind together to inflict damage on a host organism. Rather than targeting the anthrax bacterium or toxin - the approach taken by the majority of current therapies - the new inhibitor blocks the receptors where anthrax toxin attaches in the body. And because the nanoscale assembly of molecules is designed to bind to multiple sites on the host receptor, it is naturally more potent.

The new approach led to a 50,000-fold increase in potency in cell culture, and the inhibitor protected rats from anthrax toxin in the study. The general concept also could be applied to designing inhibitors for other pathogens, including SARS, influenza, and AIDS, the researchers note.

ncreased research on possible therapeutics and vaccines to treat toxins that could be used as biological weapons. The current treatment for anthrax exposure is antibiotics, but the emergence of antibiotic-resistant strains calls for new approaches to designing therapeutics for bioterrorism agents, according to Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer and corresponding author of the PNAS paper.

Pathogens such as anthrax can become resistant to antibiotics through natural processes, but resistance also can be engineered intentionally. The team's new approach co
'"/>

Contact: Jason Gorss
gorssj@rpi.edu
518-276-6098
Rensselaer Polytechnic Institute
28-Aug-2006


Page: 1 2 3

Related biology news :

1. Taming the anthrax threat
2. New finding points way to foiling anthraxs tricks
3. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
4. Combating anthrax: Results of study published this month as researchers look for a better vaccine
5. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
6. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax
7. Scientists design potent anthrax toxin inhibitor
8. Newly discovered protein kills anthrax bacteria by exploding their cell walls
9. Driver of anthrax toxicity could lead to late-stage therapy
10. UCSD study finds anthrax toxins also harmful to fruit flies
11. UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... , Mar 23, 2017 Research ... Products: Global Markets" report to their offering. ... The Global ... $466.6 Billion in 2016 at a CAGR of 8.9%, ... energetic and non-energetic bioproducts into seven major product segments: bio-derived ...
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
Breaking Biology Technology:
Cached News: